nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Novel Formulation of Mometasone Furoate in Psoriasis Patients: A Multicenter, Randomized, Double-Blind Clinical Study
|
Berg, Mats |
|
2013 |
30 |
5 |
p. 503-516 |
artikel |
2 |
Assessment of Alveolar Bone Mineral Density as a Predictor of Lumbar Fracture Probability
|
Takaishi, Yoshitomo |
|
2013 |
30 |
5 |
p. 487-502 |
artikel |
3 |
Assessment of Alveolar Bone Mineral Density as a Predictor of Lumbar Fracture Probability
|
Takaishi, Yoshitomo |
|
|
30 |
5 |
p. 487-502 |
artikel |
4 |
Efficacy and Safety of Certolizumab Pegol for Crohn’s Disease: A Systematic Review and Meta-Analysis
|
Da, Wei |
|
2013 |
30 |
5 |
p. 541-553 |
artikel |
5 |
Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use
|
Jain, Rakesh |
|
2013 |
30 |
5 |
p. 472-486 |
artikel |
6 |
Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)
|
Tamura, Yuichi |
|
2013 |
30 |
5 |
p. 554-555 |
artikel |
7 |
Erratum to: Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with a Pulmonary Arterial Hypertension (EPITOME4)
|
Tamura, Yuichi |
|
|
30 |
5 |
p. 554-555 |
artikel |
8 |
Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with Pulmonary Arterial Hypertension (EPITOME4)
|
Tamura, Yuichi |
|
2013 |
30 |
5 |
p. 459-471 |
artikel |
9 |
Immunogenicity and Safety of a Meningococcal Serogroup A, C, Y and W Glycoconjugate Vaccine, ACWY-TT
|
Findlow, Helen |
|
|
30 |
5 |
p. 431-458 |
artikel |
10 |
Immunogenicity and Safety of a Meningococcal Serogroup A, C, Y and W Glycoconjugate Vaccine, ACWY-TT
|
Findlow, Helen |
|
2013 |
30 |
5 |
p. 431-458 |
artikel |
11 |
Long-Term Effects of Beraprost Sodium on Arteriosclerosis Obliterans: a Single-Center Retrospective Study of Japanese Patients
|
Arai, Tadashi |
|
2013 |
30 |
5 |
p. 528-540 |
artikel |
12 |
Tumor Necrosis Factor-Blocker Dose Escalation in Rheumatoid Arthritis Patients in a Pharmacy Benefit Management Setting
|
Blume, Steven W. |
|
2013 |
30 |
5 |
p. 517-527 |
artikel |